Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pippa Newell

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Surgery|April 18, 2013
Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approachPippa Newell, Ben Cottam, Talicia Savage, et al.
Plos One|August 13, 2013
The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumorMarka R Crittenden, Talicia Savage, Benjamin Cottam, et al.
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
Oncotarget|September 8, 2016
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapyMarka R Crittenden, Jason Baird, David Friedman, et al.
Plos One|February 7, 2019
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinomaAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinomaTodd Crocenzi, Benjamin Cottam, Pippa Newell, et al.
Journal of Hepatology|August 12, 2009
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell, Sara Toffanin, Augusto Villanueva, et al.
Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Surgery|April 18, 2013
Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approachPippa Newell, Ben Cottam, Talicia Savage, et al.
Plos One|August 13, 2013
The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumorMarka R Crittenden, Talicia Savage, Benjamin Cottam, et al.
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
Oncotarget|September 8, 2016
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapyMarka R Crittenden, Jason Baird, David Friedman, et al.
Plos One|February 7, 2019
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinomaAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinomaTodd Crocenzi, Benjamin Cottam, Pippa Newell, et al.
Journal of Hepatology|August 12, 2009
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell, Sara Toffanin, Augusto Villanueva, et al.
Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.
Pageof 2